Liam J. Kelly

Chairman, President, and Chief Executive Officer at TELEFLEX

Board

Since January 2018

Age

58 years

Tenure

Has served at Teleflex Incorporated since at least April 2009, progressing through roles from Vice President of Marketing for the EMEA segment to Executive Vice President roles, President of international segments, President and Chief Operating Officer, and ultimately becoming President and CEO in January 2018 with an additional promotion to Chairman in May 2020.

Also at TELEFLEX

CPH

Cameron P. Hicks

Corporate Vice President, Human Resources and Communications

DVL

Daniel V. Logue

Corporate Vice President, General Counsel, and Secretary

James Winters

Corporate Vice President, Manufacturing and Supply Chain

About

Liam J. Kelly is the current Chairman, President, and Chief Executive Officer at Teleflex Incorporated, where he leverages a strong international background and decades of experience in the medical device industry.

He embarked on his Teleflex career in April 2009, and over the years, he has held several key positions including Vice President of Marketing for the EMEA segment, followed by diverse roles as Executive Vice President and President across multiple regions. This progression culminated in his appointment as President and CEO in January 2018, with a subsequent elevation to Chairman in May 2020.

In addition to his executive roles, he has broadened his influence in the industry by serving as a director at Enovis Corporation and contributing significantly to strategic planning and operational excellence at Teleflex. His international perspective, bolstered by his roots in Ireland, has been a driving force behind his commitment to global growth and innovation.

$TFX Performance Under Liam J. Kelly

Past Roles

Organization /	Role /	Date Range /	Details
Teleflex Incorporated (TFX)	President and Chief Operating Officer	May 2016 - December 2017	N/A
Teleflex Incorporated (TFX)	Executive Vice President and Chief Operating Officer	April 2015 - April 2016	N/A
Teleflex Incorporated (TFX)	Executive Vice President and President, Americas	April 2014 - April 2015	N/A
Teleflex Incorporated (TFX)	Executive Vice President and President, International	June 2012 - April 2014	N/A
Teleflex Incorporated (TFX)	President, EMEA Segment	June 2011 - June 2012	N/A
Teleflex Incorporated (TFX)	Executive Vice President, EMEA Segment	November 2009 - June 2011	N/A
Teleflex Incorporated (TFX)	Vice President of Marketing, EMEA Segment	April 2009 - November 2009	N/A
Hill-Rom Holdings, Inc.	Vice President of International Marketing and R&D	August 2006 - February 2009	N/A
Hill-Rom Holdings, Inc.	Various Senior-level Positions	October 2002 - April 2009	N/A

External Roles

Organization	Role	Date Range	Details
Enovis Corporation (formerly Colfax Corporation)	Director	N/A	Current active board position

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$1,060,150	Annual	Fixed base salary for 2023.
Health Benefits	$41,223	Post-termination benefits	Potential post-termination health benefits.
Life and Accident Insurance	$12,456	Post-termination benefits	Potential post-termination life and accident insurance benefits.
Automobile Allowance	$57,266	Post-termination benefits	Potential post-termination automobile allowance.
Deferred Compensation Contributions	Executive: $340,668; Registrant: $109,160	As specified in plan	Combination of executive and registrant contributions to the deferred compensation plan.

Performance Compensation

Data from FY 2023

Annual Incentive Program

Component Name	Weight	Target Award	Actual Award	Threshold/Maximum Payout	Vesting Schedule	Evaluation Period	Additional Details
Corporate Revenue	40%	$476,967	$476,967	Award achieved at 90.0% of target	N/A (cash-based)	Fiscal Year 2023	Adjusted for foreign currency effects and acquisitions/divestitures.
EPS	35%	N/A	$512,299	Performance at 110.5% of target	N/A (cash-based)	Fiscal Year 2023	Adjusted EPS excluding restructuring and special charges; Related grant date: Feb 21, 2023.
Cash Flow	15%	100% at target	$138,835	Payout range: Minimum 25%, up to 200%	N/A (cash-based)	Fiscal Year 2023	Adjustments applied for acquisitions, divestitures, and extraordinary items.
Individual Performance	10%	N/A	$132,519	Achieved 100% of target	N/A (cash-based)	Fiscal Year 2023	Based on strategic, organizational, and management development initiatives.

Equity Incentive Compensation

Component Name	Grant Date	Vesting Schedule	Quantity/Number	Fair Value / Price	Weight of Equity Incentive	Additional Details
Stock Options	Feb 28, 2023	Equal annual increments over first three anniversaries	46,904 shares	Fair Value: $76.22 per share ; Exercise Price: $238.23	55% of total equity incentive	Performance based on stock price appreciation; no specific performance thresholds.
Restricted Stock Units (RSUs)	Feb 28, 2023	Vest on third anniversary (Feb 28, 2026)	6,733 units	Fair Value: $241.35 per unit	25% of total equity incentive	Total Grant Value: $1,625,000; time-based award with no performance targets.
Performance Stock Units (PSUs)	Feb 21, 2023	Performance-based vesting using RTSR Modifier	Target: 5,150 units ; Max: 12,875 units	Target Fair Value: $1,257,012 ; Maximum: $3,142,530 ; Market Price: $249.34	20% of total equity incentive	Vesting contingent on stock price performance relative to a peer group (RTSR Modifier).